BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4093126)

  • 1. Pathophysiological aspects of dacarbazine-induced human liver damage.
    Paschke R; Heine M
    Hepatogastroenterology; 1985 Dec; 32(6):273-5. PubMed ID: 4093126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dacarbazine in malignant melanoma. Rare, severe side-effect: Budd-Chiari-syndrome (author's transl)].
    Doering C; Pickartz H; Orfanos CE; Altenähr E
    Z Hautkr; 1982 Jul; 57(13):971-80. PubMed ID: 7113323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic veno-occlusive disease due to DTIC.
    Asbury RF; Rosenthal SN; Descalzi ME; Ratcliffe RL; Arseneau JC
    Cancer; 1980 May; 45(10):2670-4. PubMed ID: 7379000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Veno-occlusive liver disease after dacarbazine therapy (DTIC) for melanoma.
    Erichsen C; Jönsson PE
    J Surg Oncol; 1984 Dec; 27(4):268-70. PubMed ID: 6503301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Budd-Chiari syndrome in DTIC therapy].
    Swensson-Beck H; Trettel WH
    Hautarzt; 1982 Jan; 33(1):30-1. PubMed ID: 7085277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Veno-occlusive syndrome with acute liver dystrophy following decarbazine therapy of malignant melanoma (author's transl)].
    Voigt H; Caselitz J; Jänner M
    Klin Wochenschr; 1981 Mar; 59(5):229-36. PubMed ID: 7218735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatal hepatic vascular toxicity of DTIC. Is it really a rare event?
    Ceci G; Bella M; Melissari M; Gabrielli M; Bocchi P; Cocconi G
    Cancer; 1988 May; 61(10):1988-91. PubMed ID: 3359400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Budd-Chiari syndrome following dacarbazine therapy of malignant melanoma--an avoidable complication?].
    Leyh F; Winzer M; Weber M; Hypa F
    Z Hautkr; 1985 Jun; 60(12):961-72. PubMed ID: 4024678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic failure in a patient treated with dacarbazine (DTIC) for malignant melanoma.
    Frosch PJ; Czarnetzki BM; Macher E; Grundmann E; Gottschalk I
    J Cancer Res Clin Oncol; 1979; 95(3):281-6. PubMed ID: 528568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dacarbazine (DTIC) therapy and the Budd-Chiari syndrome].
    Balda BR; Bassermann R
    MMW Munch Med Wochenschr; 1980 May; 122(21):792-4. PubMed ID: 6771598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Budd-Chiari syndrome during treatment with dacarbazine (DTIC) (author's transl)].
    Runne U; Doepfmer K; Antz H; Groth W; FEAUX DE Lacroix W
    Dtsch Med Wochenschr; 1980 Feb; 105(7):230-3. PubMed ID: 6986251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allergy-induced hepatic toxicity associated with dacarbazine.
    McClay E; Lusch CJ; Mastrangelo MJ
    Cancer Treat Rep; 1987 Feb; 71(2):219-20. PubMed ID: 3802121
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatic vascular lesions associated with dacarbazine treatment.
    Greenstone MA; Dowd PM; Mikhailidis DP; Scheuer PJ
    Br Med J (Clin Res Ed); 1981 May; 282(6278):1744-5. PubMed ID: 6786601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Veno-occlusive disease and peliosis of the liver after thorotrast administration.
    Dejgaard A; Krogsgaard K; Jacobsen M
    Virchows Arch A Pathol Anat Histopathol; 1984; 403(1):87-94. PubMed ID: 6426155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute liver dystrophy with thrombosis of hepatic veins: a fatal complication of dacarbazine treatment.
    Féaux de Lacroix W; Runne U; Hauk H; Doepfmer K; Groth W; Wacker D
    Cancer Treat Rep; 1983 Sep; 67(9):779-84. PubMed ID: 6883354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fine structure of the liver in experimental veno-occlusive disease.
    Putzke HP; Persaud TV; Bienengräber A
    Exp Pathol (Jena); 1972; 6(5):325-32. PubMed ID: 4665951
    [No Abstract]   [Full Text] [Related]  

  • 17. [Drugs and vascular hepatic lesions].
    Adler M; De Prez C; Rickaert F; Bourgeois N; Cremer M
    Acta Gastroenterol Belg; 1988; 51(1):83-9. PubMed ID: 3055789
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug-induced vascular and sinusoidal lesions of the liver.
    Valla D; Benhamou JP
    Baillieres Clin Gastroenterol; 1988 Apr; 2(2):481-500. PubMed ID: 3044472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Veno-occlusive disease of the liver after chemotherapy of acute leukemia. Report of two cases.
    Griner PF; Elbadawi A; Packman CH
    Ann Intern Med; 1976 Nov; 85(5):578-82. PubMed ID: 1068643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute hepatic vein thrombosis occurring during therapy for Hodgkin's disease: a case report.
    Houghton AN; Shafi N; Rickles FR
    Cancer; 1979 Dec; 44(6):2324-9. PubMed ID: 509400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.